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A B S T R A C T
Postcardiac injury syndrome occurs as a complication of myocardial infarction 
(Dressler’s syndrome), of cardiac surgery (post-pericardiotomy syndrome), or post-
traumatic (either iatrogenic or non-iatrogenic) and involves a pericardial or myocardial 
injury. There is scarce data regarding occurrence and pathogenesis of postcardiac in-
jury syndrome after invasive procedures. Herein, we describe a rare case of acute post-
cardiac injury syndrome with typical clinical, laboratory, echocardiographic findings 
that occurred one hour after a demanding multi-stenting percutaneous coronary inter-
vention. Possible pathogenetic mechanisms and treatment options are being discussed.
I n T R o d u C T I o n
Postcardiac injury syndrome (PCIS) occurs as a complication of myocardial in-
farction (Dressler’s syndrome), of cardiac surgery [post-pericardiotomy syndrome 
(PPS)], or post-traumatic (iatrogenic or non-iatrogenic) and involves a pericardial or 
myocardial injury.1 PCIS is characterized by inflammation of the pericardium, pleura, 
and pulmonary parenchyma following a cardiac injury; the typical patient presents with 
chest pain that is usually pleuritic in nature, fever, irritability, pericardial friction rub, 
and pericardial effusion with or without pleural effusion.1 PCIS following percutaneous 
cardiac intervention (PCI) is not frequently encountered with an incidence of less than 
0.5%.1 Herein, we describe a rare case of acute PCIS with typical clinical, laboratory, 
echocardiographic findings that occurred one hour after a demanding multi-stenting 
PCI. Possible pathogenetic mechanisms and therapeutic dilemmas are being discussed.
C A S e  R e p o R T
A 51-year-old ex-smoker, male patient, with medical history of dyslipidemia and 
prior inferior ST-elevation myocardial infarction (STEMI), but with no critical coronary 
CASe RepoRT
Department of Cardiology, “Elpis” 
General Hospital of Athens, Athens, 
Greece
HOSPITAL CHRONICLES 2018, 13(1-4): 27–31
Correspondence to:
Gerasimos Gavrielatos, MD, MSc, FESC
Consultant Interventional Cardiologist, 
Department of Cardiology, 
Elpis General Hospital of Athens,  
7 Dimitsanas street, Athens, Greece
Tel.: +30 213 2039023 
Fax: +30 213 2039148
E-mail: makisgab@yahoo.gr
Manuscript received June 18, 2018; 
revised manuscript received February 5, 2019; 
Accepted February 27, 2019
Key WoRdS: Post cardiac injury 
syndrome, inflammation, percutaneous 
coronary intervention
Disclosures: The authors report no relationships that could be construed as a conflict of interest.
List of AbbreviAtions: 
AMI: Acute myocardial infraction
BMW: Balance Middleweight





EBU: Extra Back Up 
ESR: Erythrocyte sedimentation rate
JR: Judkins Right
LAD: Left anterior descending
LCx: Left circumflex
LVEF: Left ventricle ejection fraction 
OM: Obtuse marginal 
PCI: Percutaneous cardiac intervention 
PCIS: Postcardiac injury syndrome
PPS: Post-pericardiotomy syndrome
RCA: Right coronary artery 
STEMI: ST-elevation myocardial infarction 
WBC: White blood cells
28
HOSPITAL CHRONICLES 13(1-4), 2018
artery stenosis on previous coronary angiography (CANG), 
was transferred to our hospital for immediate reperfusion due 
to acute posterior-inferior STEMI, after medication discontin-
uation. The ECG at the emergency room showed ST-segment 
elevation in the inferior leads (II, III, aVF), ST-segment 
depression in the lateral leads (I, aVL, V5, V6), ST-segment 
depression in the septal and anterior precordial leads (V1-4), 
an R/S wave ratio >1 in lead V1, and ST-segment elevation in 
the posterior leads (V7-9). The laboratory assessment revealed 
evidence of myocardial injury, with a high-sensitive Troponin-
I count of 1,125 pg/ml (normal range 0.0-34.2) and creatine 
phosphokinase (CPK) 562 IU/l (normal range 39-308), while 
white blood cell (WBC) count and C-reactive protein (CRP) 
levels were normal. The initial echocardiographic evalua-
tion showed inferior wall hypokinesia with mild reduced left 
ventricle systolic function [left ventricular ejection fraction 
(LVEF): 50%], mild mitral regurgitation and mild tricuspid 
regurgitation. The patient entered the catheterization labora-
tory hemodynamically unstable (BP=85/55 mmHg, HR= 90 
beats/min), under inotropic IV infusion, and the subsequent 
CANG via the transradial approach revealed severe three-
vessel coronary artery disease (CAD). More specifically, 
CANG showed a normal left main (LM), a total occlusion 
with a thrombus in the middle segment of the right coronary 
artery (RCA), mid-left anterior descending (LAD) 99% ste-
nosis, proximal left circumflex (LCx) 70% stenosis, first obtuse 
marginal (OM1) 99% stenosis and second obtuse marginal 
(OM2) 80% stenosis. Primary PCI of RCA was immediately 
performed (Fig. 1a-d). The RCA was cannulated with a Jud-
kins Right (JR) 4 6F guiding catheter. The lesion was crossed 
FIguRe 1. a. RAO CAU view showing severe lesions in LCx and 2nd OM (arrows). b. CRA view showing a 99% stenosis in mid-
RCA. c. RCA Stent deployment and d. Final RCA primary PCI result. e. and f. LAD stent deployment and final result. g. Guidewire 
in LCx and unsuccessful attempts to place a wire distally in 2nd OM. h. Guidewire successfully crossed the lesion in 2nd OM. i. Stent 
deployment in distal LCx. j. Stent in 2nd OM with protrusion in proximal LCx. k. Stent with Cullote Technique in between prox-LCx 
and 2nd OM. l. Final LCx and 2nd OM stenting result.
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with a Balance Middleweight (BMW) wire (Abbott Vascular, 
Santa Clara, California, USA) 0.014” and pre-dilatation was 
carried out with a 2.0×15 mm semi-compliant balloon Euphora 
(Medtronic, Dublin, Ireland) at 10 atm. This was followed by 
a successful deployment of a 2.75×22 mm drug-eluting stent 
(DES) Resolute Integrity (Medtronic, Dublin, Ireland) at 
14 atm. Post-dilatation with a non-compliant balloon at 20 atm 
yielded an excellent final angiographic result. The severe lesion 
in the LAD was also stented (Fig. 1e,f). The LAD was engaged 
with an Extra Back-Up catheter (EBU) 3.5 6F, the lesion was 
crossed with a BMW wire 0.014’’ and a DES Resolute Integrity 
2.75×26 mm at 12 atm was successfully implanted. A staged 
procedure, due to the chronic total occlusion of the OM2 was 
decided, and three days later, a demanding, multi-stenting 
angioplasty was performed in the LCx and the OM2 (Fig. 1g-
l). Catheterization was performed via the right radial artery 
using an EBU 3.5 6F guide catheter. The procedure started by 
entering a BMW 0.014’’ wire to the distal part of LCx. Subse-
quently, one DES Resolute Integrity 2.5×18mm was implanted 
distally in LCx (Fig. 1i) The attempt to enter a wire to OM2 
was demanding and a variety of wires with different support 
and stiffness were used, such as BMW and Intuition (Abbott 
Vascular, Santa Clara, California, USA). A BMW 0.014’’ wire 
entered finally the OM2. By using the Culotte technique, one 
DES Resolute Integrity 2.75×22mm in the proximal LCx and 
one DES Resolute Integrity 2.75×26mm in the OM2 were 
deployed with an excellent final angiographic result. In total, 
two DESs containing zotarolimus were implanted in the first 
procedure and three more in the second one.
Almost an hour after the second procedure, the patient 
developed severe chest pain that was pleuritic in nature, 
tachypnea (26 breaths/min), and a BP=90/60 mmHg with 
core temperature level of 37.7°C. The ECG showed wide-
spread concave ST segment elevations (Fig. 2a,b). Physical 
FIguRe 2. a. Post PCI ECG. b. ECG 30 minutes later on symptoms onset with ST segment elevation in all leads. c. Chest X-ray 
at admission. d. Chest X-ray within one hour after symptoms onset showing bilateral pleural effusion. e. and f. Pericardial effusion 
growing fast within 2 hours after symptoms onset. g. Pericardial effusion regression 24h later.
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examination revealed rales at both lung bases, while the serum 
creatinine kinase and high-sensitivity troponin-I levels were not 
suggestive of a new ischemic event. The lab results indicated 
the presence of inflammation; the WBC count (19.4×109/L), 
erythrocyte sedimentation rate (ESR, 90 mm/h), and serum 
CRP levels (22.39 mg/dl, normal range <0.3) were all elevated. 
The new chest X-ray that was performed showed bilateral pleu-
ral effusions (Fig. 2c,d). The bedside echocardiogram revealed 
the presence of a small pericardial effusion (Fig. 2e), that was 
not evident in the echocardiogram performed at the patient’s 
admission and a day after the first PCI. The serial echocar-
diograms that were performed showed a gradually expanding 
(from small to medium) pericardial effusion within an hour 
of symptoms onset (Fig. 2f), followed by dyspnea and chest 
pain intensification. No common echocardiographic findings 
of cardiac tamponade, such as collapse of cardiac chambers 
were observed. Our diagnosis was that the patient had an acute 
pleuropericarditis (PCIS) and he was immediately started on 
methylprednisone and aspirin. The patient clinically improved 
within 24 hours with a significant decrease in the pericardial 
effusion (Fig. 2g), whereas the inflammatory markers gradually 
decreased. His hospitalization was thereafter uncomplicated 
and he was discharged 10 days later with the recommendation 
to be followed-up at our outpatient department. Discharge 
medication included: Aspirin, ticagrelor, atorvastatin, ramipril, 
metoprolol, methylprednisone, with instructions of tapering, 
pantoprazole and colchicine. At one-month follow-up the 
patient was asymptomatic with no pericardial effusion.
d I S C u S S I o n
The term PCIS describes the occurrence of pericarditis 
during the post-myocardial infarction period or post-pericar-
diotomy or post-cardiac trauma.1 PCIS also has been observed 
after invasive cardiac procedures.2,3 The diagnosis depends on 
the characteristic clinical and imaging features often supported 
by laboratory findings like leukocytosis, elevated ESR and 
serum CRP level.1 In order to diagnose PCIS at least two of 
the following features have to be met: fever without alternative 
causes, pleuritic chest pain, friction rub and evidence of new 
or worsening pleural or pericardial effusion.4
The pathogenesis of the PCIS is not completely under-
stood. An injury-mediated activation of autoimmune mecha-
nism involving circulating myocardial antigens and initiation of 
antigen specific responses have been suggested which leads to 
a generalized inflammatory response and pleuropericarditis.1 
Detectable anti-myosin antibody titers occur actually in every 
case of PCIS and are positively correlated with syndrome’s 
severity.1 Another reported mechanism suggests that endo-
thelial injury and leakage of blood into the pericardial space 
may trigger PCIS development.3 PCIS after acute myocardial 
infarction (AMI) appears to have largely disappeared in the 
reperfusion era and has been reported in only 0.5% of patients 
after thrombolysis.5 Imazio et al, demonstrated that early PCIS 
after AMI (within the first 4 days after AMI) in the primary 
PCI era is recorded in about 4% of patients, related to late 
presentation (>6 hours delay) and PCI failure.5 
In our case PCIS developed very early, which to the best 
of our knowledge is one of the few cases reported in the 
literature with a rapid PCIS onset after multi-stenting PCI. 
A literature review revealed only three cases of early PCIS 
after stenting, one case four hours post-PCI, and the other 
two, three hours after the procedure.2,3,6 The rapid clinical 
and laboratory manifestations in combination with the prompt 
response to the aspirin/prednisone treatment allows us to 
characterize it as acute PCIS, well-described but not fully 
understood. The numerous failed attempts to place a wire in 
the OM2 followed by complex intervention (wire switching, 
kissing balloon, post-dilatation with non-compliant balloon) 
may have caused prolonged, permanent endothelial damage 
enough to induce PCIS. This endothelial injury combined 
with negative remodeling due to the recent acute myocardial 
damage (sympathetic system activation with epinephrine and 
renin-angiotensin system involvement) may have induced the 
expression of adhesion molecules on the endothelial cells to 
which recruited inflammatory cells adhere and translocate to 
the arterial wall. As a result, an acute phase reaction, like the 
one mounted during an inflammatory response, may be pro-
voked, with mast cell and macrophage activation, causing the 
release of cytokines, including IL-1, IL-6, TNF-α, and acute-
phase proteins able to induce an immune response, expressed 
as pleuropericarditis due to mechanical injury. Subsequently, 
the released proinflammatory cytokines and chemokines could 
have resulted in the immune reaction that caused the acute 
PCIS. Another potential pathophysiological mechanism, given 
the fact that the PCIS occurred three days after the STEMI, 
may be the prior stimulation of the immune system due to the 
release of cardiac antigens as a result to the injury caused by 
the recent STEMI.
Prevention is not usually an issue in pericarditis during the 
post-myocardial infarction period due to its low incidence.7 
However, PPS significantly contributes to morbidity in patients 
after cardiac surgery. Postoperative colchicine decreased the 
risk of PPS with the cost of increased gastrointestinal adverse 
effects which reduced the potential benefits of colchicine in 
this setting.8,9
First-line drugs to treat PCIS are anti-inflammatory 
NSAID, such as ibuprofen, and colchicine. As there are no 
randomized controlled trials addressing specific treatment 
approaches for PCIS, treatment decisions must be taken with 
care given the potential side effects and risks associated with 
NSAID and colchicine in cardiac and post-surgery patients.7 
Aspirin is preferred for patients already under antiplatelet 
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therapy and known coronary artery disease. Administration 
of steroids is required only for a minority of patients with 
contraindications for NSAIDs and aspirin, known connective 
tissue disorders, severe renal failure or in case of refractory 
and severe symptoms.7 In our case, due to the rapid onset of 
symptoms and the patient’s severe clinical condition, admin-
istration of methylprednisone and aspirin was decided for 
immediate symptom relief.
C o n C l u S I o n
This is a report describing the occurrence of acute inflam-
matory response, in the setting of a demanding PCI, leading to 
the under-diagnosed clinical entity of PCIS. Complex multi-
stenting PCI of severe calcific lesions may provoke the develop-
ment of PCIS and clinicians should be aware of its rare rapid 
occurrence in order to diagnose it fast and treat it properly.
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